Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Hövelmeyer N[au]:

Isolation of T cells from the gut. Reißig S et al. Methods Mol Biol. (2014)

Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling. Hahn M et al. Leukemia. (2018)

Past, present and future of immunology in Mainz. Waisman A et al. Cell Immunol. (2016)

Search results

Items: 30

1.

Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.

Elßner C, Goeppert B, Longerich T, Scherr AL, Stindt J, Nanduri LK, Rupp C, Kather JN, Schmitt N, Kautz N, Breuhahn K, Ismail L, Heide D, Hetzer J, García-Beccaria M, Hövelmeyer N, Waisman A, Urbanik T, Mueller S, Gdynia G, Banales JM, Roessler S, Schirmacher P, Jäger D, Schölch S, Keitel V, Heikenwalder M, Schulze-Bergkamen H, Köhler BC.

Gastroenterology. 2019 Mar;156(4):1190-1205.e14. doi: 10.1053/j.gastro.2018.11.018. Epub 2018 Nov 13.

PMID:
30445013
2.

Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis.

Tang Y, Reissig S, Glasmacher E, Regen T, Wanke F, Nikolaev A, Gerlach K, Popp V, Karram K, Fantini MC, Schattenberg JM, Galle PR, Neurath MF, Weigmann B, Kurschus FC, Hövelmeyer N, Waisman A.

Gastroenterology. 2019 Feb;156(3):692-707.e7. doi: 10.1053/j.gastro.2018.10.023. Epub 2018 Oct 10.

PMID:
30315770
3.

mTORC1 activation in B cells confers impairment of marginal zone microarchitecture by exaggerating cathepsin activity.

Meena NK, Pattanayak SP, Ben-Nun Y, Benhamron S, Kumar S, Merquiol E, Hövelmeyer N, Blum G, Tirosh B.

Immunology. 2018 Dec;155(4):505-518. doi: 10.1111/imm.12996. Epub 2018 Sep 16.

PMID:
30144045
4.

Obesity exacerbates colitis-associated cancer via IL-6-regulated macrophage polarisation and CCL-20/CCR-6-mediated lymphocyte recruitment.

Wunderlich CM, Ackermann PJ, Ostermann AL, Adams-Quack P, Vogt MC, Tran ML, Nikolajev A, Waisman A, Garbers C, Theurich S, Mauer J, Hövelmeyer N, Wunderlich FT.

Nat Commun. 2018 Apr 25;9(1):1646. doi: 10.1038/s41467-018-03773-0.

5.

Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation.

Gehrke N, Hövelmeyer N, Waisman A, Straub BK, Weinmann-Menke J, Wörns MA, Galle PR, Schattenberg JM.

J Hepatol. 2018 May;68(5):986-995. doi: 10.1016/j.jhep.2018.01.008. Epub 2018 Jan 31.

PMID:
29366909
6.

Balanced Bcl-3 expression in murine CD4+ T cells is required for generation of encephalitogenic Th17 cells.

Mufazalov IA, Kuschmann J, Andruszewski D, Masri J, Gabriel LA, Adams P, Reissig S, Hövelmeyer N, Waisman A.

Eur J Immunol. 2017 Aug;47(8):1335-1341. doi: 10.1002/eji.201746933. Epub 2017 Jun 29.

7.

Aberrant splicing of the tumor suppressor CYLD promotes the development of chronic lymphocytic leukemia via sustained NF-κB signaling.

Hahn M, Bürckert JP, Luttenberger CA, Klebow S, Hess M, Al-Maarri M, Vogt M, Reißig S, Hallek M, Wienecke-Baldacchino A, Buch T, Muller CP, Pallasch CP, Wunderlich FT, Waisman A, Hövelmeyer N.

Leukemia. 2018 Jan;32(1):72-82. doi: 10.1038/leu.2017.168. Epub 2017 Jun 1.

PMID:
28566736
8.

Elevated levels of Bcl-3 inhibits Treg development and function resulting in spontaneous colitis.

Reißig S, Tang Y, Nikolaev A, Gerlach K, Wolf C, Davari K, Gallus C, Masri J, Mufazalov IA, Neurath MF, Wunderlich FT, Schattenberg JM, Galle PR, Weigmann B, Waisman A, Glasmacher E, Hövelmeyer N.

Nat Commun. 2017 Apr 28;8:15069. doi: 10.1038/ncomms15069.

9.

Past, present and future of immunology in Mainz.

Waisman A, Hövelmeyer N, Diefenbach A, Schuppan D, Reddehase MJ, Kleinert H, Kaina B, Grabbe S, Galle PR, Theobald M, Zipp F, Sahin U, Türeci Ö, Kreiter S, Langguth P, Decker H, van Zandbergen G, Schild H.

Cell Immunol. 2016 Oct;308:1-6. doi: 10.1016/j.cellimm.2016.09.001. No abstract available.

PMID:
27719802
10.

Hepatic B cell leukemia-3 promotes hepatic steatosis and inflammation through insulin-sensitive metabolic transcription factors.

Gehrke N, Wörns MA, Huber Y, Hess M, Straub BK, Hövelmeyer N, Waisman A, Kim YO, Schuppan D, Galle PR, Schattenberg JM.

J Hepatol. 2016 Dec;65(6):1188-1197. doi: 10.1016/j.jhep.2016.06.026. Epub 2016 Jul 9.

PMID:
27405060
11.

IL-6 Signaling in Myelomonocytic Cells Is Not Crucial for the Development of IMQ-Induced Psoriasis.

Klebow S, Hahn M, Nikoalev A, Wunderlich FT, Hövelmeyer N, Karbach SH, Waisman A.

PLoS One. 2016 Mar 21;11(3):e0151913. doi: 10.1371/journal.pone.0151913. eCollection 2016.

12.

NF-κB-inducing kinase is essential for B-cell maintenance in mice.

Hahn M, Macht A, Waisman A, Hövelmeyer N.

Eur J Immunol. 2016 Mar;46(3):732-41. doi: 10.1002/eji.201546081. Epub 2015 Dec 9.

13.

IL17A-Mediated Endothelial Breach Promotes Metastasis Formation.

Kulig P, Burkhard S, Mikita-Geoffroy J, Croxford AL, Hövelmeyer N, Gyülvészi G, Gorzelanny C, Waisman A, Borsig L, Becher B.

Cancer Immunol Res. 2016 Jan;4(1):26-32. doi: 10.1158/2326-6066.CIR-15-0154. Epub 2015 Nov 19.

14.

BAX inhibitor-1 is a Ca(2+) channel critically important for immune cell function and survival.

Lisak D, Schacht T, Gawlitza A, Albrecht P, Aktas O, Koop B, Gliem M, Hofstetter HH, Zanger K, Bultynck G, Parys JB, De Smedt H, Kindler T, Adams-Quack P, Hahn M, Waisman A, Reed JC, Hövelmeyer N, Methner A.

Cell Death Differ. 2016 Feb;23(2):358-68. doi: 10.1038/cdd.2015.115. Epub 2015 Oct 16.

15.

The deubiquitinating enzyme CYLD regulates the differentiation and maturation of thymic medullary epithelial cells.

Reissig S, Hövelmeyer N, Tang Y, Weih D, Nikolaev A, Riemann M, Weih F, Waisman A.

Immunol Cell Biol. 2015 Jul;93(6):558-66. doi: 10.1038/icb.2014.122. Epub 2015 Jan 20.

PMID:
25601276
16.

CYLD deletion triggers nuclear factor-κB-signaling and increases cell death resistance in murine hepatocytes.

Urbanik T, Koehler BC, Wolpert L, Elßner C, Scherr AL, Longerich T, Kautz N, Welte S, Hövelmeyer N, Jäger D, Waisman A, Schulze-Bergkamen H.

World J Gastroenterol. 2014 Dec 7;20(45):17049-64. doi: 10.3748/wjg.v20.i45.17049.

17.

Isolation of T cells from the gut.

Reißig S, Hackenbruch C, Hövelmeyer N.

Methods Mol Biol. 2014;1193:21-5. doi: 10.1007/978-1-4939-1212-4_3.

PMID:
25150993
18.

Overexpression of Bcl-3 inhibits the development of marginal zone B cells.

Hövelmeyer N, Wörns MA, Reissig S, Adams-Quack P, Leclaire J, Hahn M, Wörtge S, Nikolaev A, Galle PR, Waisman A.

Eur J Immunol. 2014 Feb;44(2):545-52. doi: 10.1002/eji.201343655. Epub 2013 Nov 18.

19.

Mechanisms of chronic JAK-STAT3-SOCS3 signaling in obesity.

Wunderlich CM, Hövelmeyer N, Wunderlich FT.

JAKSTAT. 2013 Apr 1;2(2):e23878. doi: 10.4161/jkst.23878. Review.

20.

The tumor suppressor CYLD controls the function of murine regulatory T cells.

Reissig S, Hövelmeyer N, Weigmann B, Nikolaev A, Kalt B, Wunderlich TF, Hahn M, Neurath MF, Waisman A.

J Immunol. 2012 Nov 15;189(10):4770-6. doi: 10.4049/jimmunol.1201993. Epub 2012 Oct 12.

21.

Liver specific deletion of CYLDexon7/8 induces severe biliary damage, fibrosis and increases hepatocarcinogenesis in mice.

Urbanik T, Boger RJ, Longerich T, Becker K, Ehrenberg KR, Hövelmeyer N, Hahn M, Schuchmann M, Jäger D, Waisman A, Wörns MA, Schulze-Bergkamen H.

J Hepatol. 2012 Nov;57(5):995-1003. doi: 10.1016/j.jhep.2012.06.017. Epub 2012 Jun 21.

PMID:
22728872
22.

A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies.

Hövelmeyer N, Reissig S, Xuan NT, Adams-Quack P, Lukas D, Nikolaev A, Schlüter D, Waisman A.

Eur J Immunol. 2011 Mar;41(3):595-601. doi: 10.1002/eji.201041313. Epub 2011 Feb 10.

23.

Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.

Urbanik T, Köhler BC, Boger RJ, Wörns MA, Heeger S, Otto G, Hövelmeyer N, Galle PR, Schuchmann M, Waisman A, Schulze-Bergkamen H.

Int J Oncol. 2011 Jan;38(1):121-31.

PMID:
21109933
24.

Mutated cylindromatosis gene affects the functional state of dendritic cells.

Bros M, Dexheimer N, Besche V, Masri J, Trojandt S, Hövelmeyer N, Reissig S, Massoumi R, Grabbe S, Waisman A, Reske-Kunz AB.

Eur J Immunol. 2010 Oct;40(10):2848-57. doi: 10.1002/eji.200939285.

25.

Smad7 in T cells drives T helper 1 responses in multiple sclerosis and experimental autoimmune encephalomyelitis.

Kleiter I, Song J, Lukas D, Hasan M, Neumann B, Croxford AL, Pedré X, Hövelmeyer N, Yogev N, Mildner A, Prinz M, Wiese E, Reifenberg K, Bittner S, Wiendl H, Steinman L, Becker C, Bogdahn U, Neurath MF, Steinbrecher A, Waisman A.

Brain. 2010 Apr;133(Pt 4):1067-81. doi: 10.1093/brain/awq039. Epub 2010 Mar 30.

26.

Naturally occurring short splice variant of CYLD positively regulates dendritic cell function.

Srokowski CC, Masri J, Hövelmeyer N, Krembel AK, Tertilt C, Strand D, Mahnke K, Massoumi R, Waisman A, Schild H.

Blood. 2009 Jun 4;113(23):5891-5. doi: 10.1182/blood-2008-08-175489. Epub 2009 Apr 2.

27.

Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD.

Hövelmeyer N, Wunderlich FT, Massoumi R, Jakobsen CG, Song J, Wörns MA, Merkwirth C, Kovalenko A, Aumailley M, Strand D, Brüning JC, Galle PR, Wallach D, Fässler R, Waisman A.

J Exp Med. 2007 Oct 29;204(11):2615-27. Epub 2007 Oct 8.

28.

Apoptosis of oligodendrocytes via Fas and TNF-R1 is a key event in the induction of experimental autoimmune encephalomyelitis.

Hövelmeyer N, Hao Z, Kranidioti K, Kassiotis G, Buch T, Frommer F, von Hoch L, Kramer D, Minichiello L, Kollias G, Lassmann H, Waisman A.

J Immunol. 2005 Nov 1;175(9):5875-84.

29.

Experimental autoimmune encephalomyelitis repressed by microglial paralysis.

Heppner FL, Greter M, Marino D, Falsig J, Raivich G, Hövelmeyer N, Waisman A, Rülicke T, Prinz M, Priller J, Becher B, Aguzzi A.

Nat Med. 2005 Feb;11(2):146-52. Epub 2005 Jan 23. Erratum in: Nat Med. 2005 Apr;11(4):455.

PMID:
15665833
30.

The lack of annexin A7 affects functions of primary astrocytes.

Clemen CS, Herr C, Hövelmeyer N, Noegel AA.

Exp Cell Res. 2003 Dec 10;291(2):406-14.

PMID:
14644162

Supplemental Content

Loading ...
Support Center